News + Filings Transactions
|
Jovan-Embiricos Morana
Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
05/11/2023 | Allovir, Inc. | ALVR | Grant | Common Stock | 35k | $0.00 | $0 | | 05/11/2023 |
07/28/2022 | Allovir, Inc. | ALVR | Grant | Common Stock | 684.6k | $4.61 | $3.2M | By F2 MG Limited | 07/28/2022 |
07/28/2022 | Allovir, Inc. | ALVR | Grant | Common Stock | 325.4k | $4.61 | $1.5M | By F2-TPO Investments, LLC | 07/28/2022 |
07/28/2022 | Allovir, Inc. | ALVR | Grant | Common Stock | 1.6M | $4.61 | $7.5M | By F2 MC, LLC | 07/28/2022 |
07/28/2022 | Allovir, Inc. | ALVR | Grant | Common Stock | 1.4M | $4.61 | $6.4M | By F2 Capital I 2020 LLC | 07/28/2022 |
07/28/2022 | Allovir, Inc. | ALVR | Grant | Common Stock | 867.7k | $4.61 | $4M | By F2 Bioscience AV 2022 LLC | 07/28/2022 |
07/28/2022 | Allovir, Inc. | ALVR | Grant | Common Stock | 3.3M | $4.61 | $15M | By ElevateBio LLC | 07/28/2022 |
06/24/2022 | Cullinan Oncology, Inc. | | Exercise | Stock Option (Right to Buy) | 35.5k | $4.30 | $152.8k | | 06/24/2022 |
06/24/2022 | Cullinan Oncology, Inc. | | Exercise | Stock Option (Right to Buy) | 104.8k | $4.30 | $450.8k | | 06/24/2022 |
06/24/2022 | Cullinan Oncology, Inc. | | Payment of Exercise | Common Stock | 45.1k | $13.39 | $603.6k | | 06/24/2022 |
05/17/2022 | Allovir, Inc. | ALVR | Grant | Stock Option (Right to Buy) | 27.5k | $4.60 | $126.5k | | 05/17/2022 |
11/10/2021 | Allovir, Inc. | ALVR | Sale | Common Stock | 120 | $24.77 | $3k | By F2-TPO Investments, LLC | 11/10/2021 |
11/10/2021 | Allovir, Inc. | ALVR | Sale | Common Stock | 680 | $24.77 | $16.8k | By F2 MG Limited | 11/10/2021 |
11/09/2021 | Allovir, Inc. | ALVR | Sale | Common Stock | 3.2k | $24.79 | $80.4k | By F2 MG Limited | 11/05/2021 |
11/09/2021 | Allovir, Inc. | ALVR | Sale | Common Stock | 572 | $24.79 | $14.2k | By F2-TPO Investments, LLC | 11/05/2021 |
11/05/2021 | Allovir, Inc. | ALVR | Sale | Common Stock | 7.1k | $24.80 | $176.7k | By F2 MG Limited | 11/05/2021 |
11/05/2021 | Allovir, Inc. | ALVR | Sale | Common Stock | 1.3k | $24.80 | $31.2k | By F2-TPO Investments, LLC | 11/05/2021 |
10/27/2021 | Allovir, Inc. | ALVR | Sale | Common Stock | 1.9k | $24.78 | $46.3k | By F2 MG Limited | 10/27/2021 |
10/27/2021 | Allovir, Inc. | ALVR | Sale | Common Stock | 330 | $24.78 | $8.2k | By F2-TPO Investments, LLC | 10/27/2021 |
10/25/2021 | Allovir, Inc. | ALVR | Sale | Common Stock | 1.2k | $24.82 | $28.9k | By F2-TPO Investments, LLC | 10/21/2021 |
10/25/2021 | Allovir, Inc. | ALVR | Sale | Common Stock | 6.6k | $24.82 | $163.9k | By F2 MG Limited | 10/21/2021 |
10/22/2021 | Allovir, Inc. | ALVR | Sale | Common Stock | 859 | $24.77 | $21.3k | By F2-TPO Investments, LLC | 10/21/2021 |
10/22/2021 | Allovir, Inc. | ALVR | Sale | Common Stock | 4.9k | $24.77 | $120.5k | By F2 MG Limited | 10/21/2021 |
10/21/2021 | Allovir, Inc. | ALVR | Sale | Common Stock | 15 | $24.75 | $371.2 | By F2-TPO Investments, LLC | 10/21/2021 |
10/21/2021 | Allovir, Inc. | ALVR | Sale | Common Stock | 85 | $24.75 | $2.1k | By F2 MG Limited | 10/21/2021 |
09/16/2021 | Cullinan Oncology, Inc. | | Grant | Stock Option (Right to Buy) | 7.8k | $28.80 | $224.6k | | 09/16/2021 |
05/25/2021 | Allovir, Inc. | ALVR | Grant | Stock Option (Right to Buy) | 22.5k | $21.51 | $484k | | 05/25/2021 |
01/12/2021 | Cullinan Oncology, Inc. | | Conversion | Common Stock | 1.1M | $0.00 | $0 | See Footnote | 01/12/2021 |
01/12/2021 | Cullinan Oncology, Inc. | | Conversion | Common Stock | 2.9M | $0.00 | $0 | See Footnote | 01/12/2021 |
01/12/2021 | Cullinan Oncology, Inc. | | Conversion | Common Stock | 639.3k | $0.00 | $0 | See Footnote | 01/12/2021 |
01/12/2021 | Cullinan Oncology, Inc. | | Conversion | Common Stock | 455.3k | $0.00 | $0 | See Footnote | 01/12/2021 |
01/12/2021 | Cullinan Oncology, Inc. | | Conversion | Common Stock | 182.1k | $0.00 | $0 | See Footnote | 01/12/2021 |
01/12/2021 | Cullinan Oncology, Inc. | | Conversion | Common Stock | 71.6k | $0.00 | $0 | See Footnote | 01/12/2021 |
01/12/2021 | Cullinan Oncology, Inc. | | Conversion | Common Stock | 143.2k | $0.00 | $0 | See Footnote | 01/12/2021 |
01/12/2021 | Cullinan Oncology, Inc. | | Conversion | Common Stock | 71.6k | $0.00 | $0 | See Footnote | 01/12/2021 |
|
|